DCF — NORTH AUSTIN MEDICAL CENTER
Enterprise Value: $392.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$392.6M
Enterprise Value
$99.9M
PV of Cash Flows
$292.6M
PV of Terminal Value
$471.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $634.4M | $53.9M | 9.0% | $17.6M | $16.0M |
| Year 2 | $653.5M | $62.1M | 10.0% | $23.0M | $19.0M |
| Year 3 | $673.1M | $70.7M | 11.0% | $28.7M | $21.6M |
| Year 4 | $693.3M | $76.3M | 11.0% | $32.2M | $22.0M |
| Year 5 | $714.1M | $80.3M | 11.0% | $34.5M | $21.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $392.6M. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$616.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.08000000045458154
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5